丽珠医药创新型流感疫苗I期临床试验完成受试者入组

丽珠医药
Dec 11, 2025

近日,我国多地进入流感高发期。专家指出,接种疫苗是预防流感最有效的手段,并特别建议老年人等重点群体及时接种,以降低感染与重症风险。丽珠医药(深交所代码:000513;香港联交所代码:01513)宣布,其创新流感疫苗LZSN2401的I期临床试验已完成所有受试者接种。初步随访观察显示,该疫苗安全性表现良好,未出现严重不良反应,为后续临床开发奠定坚实的基础。根据中国疾病预防控制中心的监测,全国流感疫情...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10